Skip to content
Catholic Online Logo

By Catholic Online (NEWS CONSORTIUM)

11/7/2012 (1 year ago)

Catholic Online (www.catholic.org)

Seralaxin reports high success rate in patients

An experimental drug, called serelaxin from the Novartis AG drug group to treat hospitalized acute heart failure patients has reported remarkable success. The death rate was decreased by as much as 37 percent compared with a placebo and appeared to be safe.

Novartis says that it now seeks approval for serelaxin. Researchers say that in a study of 1,161 patients, the drug cut deaths from any cause at six months by 37 percent and led to a marked reduction in worsening of heart failure during hospitalization.

Novartis says that it now seeks approval for serelaxin. Researchers say that in a study of 1,161 patients, the drug cut deaths from any cause at six months by 37 percent and led to a marked reduction in worsening of heart failure during hospitalization.

Highlights

By Catholic Online (NEWS CONSORTIUM)

Catholic Online (www.catholic.org)

11/7/2012 (1 year ago)

Published in Health

Keywords: Serelaxin, heart failure, mortality rate, shortness of breath


LOS ANGELES, CA (Catholic Online) - According to data from a late stage clinical trial presented this week, serelaxin, a form of a human hormone that relaxes blood vessels and eases stress on the heart and other organs, is now considered one of the most important medicines in the Swiss drug maker's developmental pipeline.

"With a meaningful mortality benefit, we believe Serelaxin could represent a $2.5 billion (annual) sales opportunity," Deutsche Bank analysts said.

Novartis says that it now seeks approval for serelaxin. Researchers say that in a study of 1,161 patients, the drug cut deaths from any cause at six months by 37 percent and led to a marked reduction in worsening of heart failure during hospitalization.

In fact, patients that received 48 hours of continuously infused serelaxin experienced more than 45 percent fewer episodes of worsening heart failure symptoms than those treated with a placebo.

Novartis had previously disclosed that serelaxin met one of the study's two primary goals measuring relief of dyspnea, or extreme shortness of breath, which is a common symptom of acute heart failure. By one measure, serelaxin led to a 19 percent improvement in dyspnea, researchers said.

The drug failed to hit a secondary goal of the study that combined cardiovascular death with need for re-hospitalizations. Researchers feel that the life saving benefit is far more important.

"We did have a startling death benefit. One of the reasons there may have been an inability to show a decrease in hospitalizations is more patients was alive to be re-hospitalized," Dr. John Teerlink, one of the trial's co-lead researchers says. A cardiologist and heart failure specialist at the San Francisco VA Medical Center says that the data showed that only 29 acute heart failure patients would have to be treated with serelaxin to prevent one cardiovascular death.

There is a pressing need for a treatment for acute heart failure, with few available options for the condition in which the heart is unable to pump enough blood.

"If it was approved we would not only use it, there would be a mandate to use it because we don't have anything for acute decompensated heart failure," Dr. Milton Packer, a prominent cardiologist from the University of Texas says.

While he was not part of the study, Packer is excited about the possibilities presented by the new drug. "If that mortality finding is real, boy, are we going to get excited!"

There are more than one million hospitalizations in the United States each year for acute heart failure and another million in Europe.

.

---


Pope Francis: end world hunger through 'Prayer and Action'


2014 - Distributed by THE NEWS CONSORTIUM

Pope Francis Prayer Intentions for July 2014
Sports:
That sports may always be occasions of human fraternity and growth.
Lay Missionaries: That the Holy Spirit may support the work of the laity who proclaim the Gospel in the poorest countries.



Comments


More Health

Light at end of tunnel? HIV epidemic could be contained by 2030 Watch

Image of While HIV, the virus that causes AIDS, continues to be an ongoing threat - more so in developing nations where education about its transmission is compromised, there now appears to be a light at the end of the tunnel.

By Catholic Online (NEWS CONSORTIUM)

While HIV, the virus that causes AIDS, continues to be an ongoing threat - more so in developing nations where education about its transmission is compromised, there now appears to be a light at the end of the tunnel. According to the United Nations, new HIV ... continue reading


Dye now being used to detect dementia Watch

Image of Researchers from Duke University Medical Center in North Carolina, tested 152 patients older than 50 years of age to see if they could predict cognitive decline by tracking changes in the brain.

By Catholic Online (NEWS CONSORTIUM)

Dementia, like Alzheimer's is a disease that usually effects the elderly. In the manner of Alzheimer's plaque begins to collect in the brain at an advanced age. This drastically effects the patient's memory, cognitive ability and motor skills, with many winding ... continue reading


Breakthrough announced in hereditary condition that causes blindness Watch

Image of The age at which symptoms start is variable and the rate of deterioration often varies. In around half of all cases there are other family members with the condition.

By Catholic Online (NEWS CONSORTIUM)

Retinitis pigmentosa, or RP is an inherited, degenerative eye disease that causes severe vision impairment and frequently leads to blindness. Affecting around one in 3,000 to 4,000 people, scientists have moved closer to a breakthrough in "personalized" ... continue reading


Deadly plague than can be spread by coughing, sneezing infects Colorado man Watch

Image of Untreated plague is always fatal. Antibiotics have to be given within 24 hours of the first symptoms to reduce the chance of death.

By Catholic Online (NEWS CONSORTIUM)

It's the first case of pneumonic plague seen in Colorado since 2004. A man there has been diagnosed with among the rarest and most fatal forms of the plague, an airborne version that can be spread through coughing and sneezing. LOS ANGELES, CA (Catholic Online) ... continue reading


Sighs of relief after vials of smallpox found Watch

Image of The FBI is investigating how the samples ended up where they did.

By Catholic Online (NEWS CONSORTIUM)

There were sighs of relief when someone made a discovery in a disused closet. Many thanked the Lord that it didn't fall into the wrong hands. An employee at the National Institutes of Health found vials of smallpox, the onetime scourge of humanity, in a storage ... continue reading


Birth control computer chip implanted under the skin 'could be on sale by 2018' Watch

Image of An international coalition of governments, companies, philanthropies and nonprofit organizations committed to providing family planning to 120 million more women in the world by 2020.

By Catholic Online (NEWS CONSORTIUM)

Long in gestation, the idea of a computer chip implanted under the skin to regulate fertility is now within throwing distance of becoming an actuality. The idea has been with us since the Nineties, and thanks to a nudge from Microsoft's Bill Gates, such as ... continue reading


New blood test could determine onset of Alzheimer's Watch

Image of The new blood test, which examines 10 proteins in the blood, can predict with 87 percent accuracy whether someone suffering memory problems will develop Alzheimer's within a year.

By Catholic Online (NEWS CONSORTIUM)

The memory-destroying condition known as Alzheimer's, preying chiefly on the elderly, has no known cure. However, after a decade of research, scientists at Oxford University and King's College London have identified 10 proteins that arise when a patient is due ... continue reading


How one fungus may stop superbugs Watch

Image of A compound taken from a fungus may prove capable of stopping drug-resistant suberbugs.

By Catholic Online (NEWS CONSORTIUM)

A new discovery out of Canada may prove an invaluable weapon in fighting antibiotic resistant and dangerous bacteria. LOS ANGELES, CA (Catholic Online) - Scientists at McMaster University in Ontario discovered a compound that instantly turned off a gene in several ... continue reading


Taking aim against child mortality, India to offer four free vaccines Watch

Image of Diarrhea caused by rotavirus kills nearly 80,000 children annually.

By Catholic Online (NEWS CONSORTIUM)

Taking aim the high mortality rate of children in many of its poor, rural areas, the nation of India will be offering four free vaccines. The no-cost vaccines are part of a program to reduce child mortality and preserve coming generations, according to Prime ... continue reading


22 million lives saved, 56 million people treated in global TB efforts Watch

Image of Archbishop Zimowski commended the summit agenda for considering approaches that have been already proven successful in charting future plans to eradicate the disease from the world.

By Catholic Online (NEWS CONSORTIUM)

While the world and the international medical community must remain ever vigilant, the World Health Organization, or WHO says that some 22 million lives were saved and 56 million people were successfully treated after Tuberculosis was declared a global health ... continue reading


All Health News

Newsletters

Newsletter Sign Up icon

Stay up to date with the latest news, information, and special offers

Daily Readings

Reading 1, Song of Songs 3:1-4
1 On my bed at night I sought the man who is my ... Read More

Psalm, Psalms 63:2, 3-4, 5-6, 8-9
2 Thus I have gazed on you in the sanctuary, seeing ... Read More

Gospel, John 20:1-2, 11-18
1 It was very early on the first day of the week and ... Read More

Saint of the Day

Saint of the Day for July 22nd, 2014 Image

St. Mary Magdelene
July 22: She is called "the Penitent". St. Mary was given the ... Read More

Inform, Inspire & Ignite Logo

Find Catholic Online on Facebook and get updates right in your live feed.

Become a fan of Catholic Online on Facebook


Follow Catholic Online on Twitter and get News and Product updates.

Follow us on Twitter